½ÃÀ庸°í¼­
»óǰÄÚµå
1339992

¼¼°èÀÇ µðÁöÅÐ ³ú °Ç°­ ½ÃÀå ¿¹Ãø(-2030³â) : ±¸¼º ¿ä¼Òº°, ±â´Éº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®

Digital Brain Health Market Forecasts to 2030 - Global Analysis By Component, Functionality, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é, ¼¼°è µðÁöÅÐ ³ú °Ç°­ ½ÃÀåÀº 2023³â 2,206¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇϰí, CAGR 9.3%¸¦ ±â·ÏÇϸç 2030³â 4,111¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

µðÁöÅÐ À£´Ï½º´Â ½ÅüÀû, Á¤½ÅÀû, ÀÎÁöÀû °Ç°­À» Áö۱â À§ÇØ ±â¼úÀ» Ȱ¿ëÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. ³úÀÇ ÀÎÁö±â´É, »çȸÁ¤¼­±â´É, °¨°¢±â´É, Çൿ±â´É, ¿îµ¿±â´ÉÀº ¸ðµÎ ³ú °Ç°­ÀÇ ÁöÇ¥ÀÔ´Ï´Ù. µðÁöÅÐ ³ú °Ç°­ ½ÃÀåÀº ÀÎÁö ±â´ÉÀ» Çâ»ó½ÃŰ°í ³ú °Ç°­À» ÁõÁø½Ã۱â À§ÇØ ±â¼ú°ú µðÁöÅÐ µµ±¸¸¦ äÅÃÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ µµ±¸´Â ÀÎÁö±â´ÉÀ» À¯ÁöÇϰųª Çâ»ó½Ã۰íÀÚ ÇÏ´Â »ç¶÷µé¿¡°Ô ½Ç¿ëÀûÀ̰í ÇÕ¸®ÀûÀÎ °¡°ÝÀÇ °³ÀÎ ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Á¦°øÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

¼¼°èÀºÇà¿¡ µû¸£¸é ¾à 10¾ï ¸íÀÌ °æµµÀÎÁöÀå¾Ö, ³­µ¶Áõ, ÁÖÀÇ·Â °áÇÌ, ¾ËÃ÷ÇÏÀ̸Ӻ´ µî Á¤½Å °Ç°­ »óŸ¦ ¾Î°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

ÃËÁø¿äÀÎ

  • ³úÁúȯ À¯º´·ü Áõ°¡
  • µðÁöÅÐ ³ú °Ç°­ ½ÃÀå ºÐ¼®¿¡ µû¸£¸é 2020³â¿¡´Â Äڷγª19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ºÒ¾ÈÀå¾Ö¿Í ¿ì¿ïÀå¾Ö°¡ ´õ ¸¹Àº »ç¶÷µé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. »ç°í, °¨Á¤ ¹× ÇൿÀÇ ÇöÀúÇÑ Àå¾Ö´Â Á¤½Å Àå¾Ö¸¦ Ư¡ Áþ´Â´Ù. Á¤½Å ºÐ¿­Áõ°ú ¿Ü»ó ÈÄ ½ºÆ®·¹½º Àå¾Ö(PTSD)´Â ´Ù¾çÇÑ Àå¾ÖÀÇ ¿¹À̸ç, WHO¿¡ µû¸£¸é ¼¼°èÀûÀ¸·Î ¾à 5,000 ¸¸ ¸íÀÌ °£Áú·Î °íÅë ¹Þ°í ÀÖ½À´Ï´Ù. ±× °á°ú, °£ÁúÀº ¼¼°èÀûÀ¸·Î °¡Àå ³Î¸® ÆÛÁ® ÀÖ´Â ½Å°æÁúȯ Áß Çϳª·Î ²ÅÈü´Ï´Ù. °£Áú ȯÀÚÀÇ 80% °¡±îÀ̰¡ ÁßÀú¼Òµæ ±¹°¡¿¡ °ÅÁÖÇϰí ÀÖ½À´Ï´Ù.

¾ïÁ¦¿äÀÎ

  • ¸ðµç ¸®¼Ò½º¿¡ Á¢±ÙÇÒ ¼ö ¾ø½À´Ï´Ù.
  • µðÁöÅÐ ³ú °Ç°­ÀÇ Àαâ´Â ºñ±³Àû »õ·Ó±â ¶§¹®¿¡ ¸ðµç ¿ëµµÀÌ ¹«·áÀÎ °ÍÀº ¾Æ´Õ´Ï´Ù. ÀϺΠ»ç¶÷µé¿¡°Ô´Â ÀÎ¾Û °áÁ¦°¡ ÀÖ´Â ¹«·á ¾ÛÀÌ ÃÖ¼±ÀÇ ¼±ÅÃÀÌ ¾Æ´Ò ¼öµµ ÀÖ½À´Ï´Ù. ÀÌ´Â ÀÌ·¯ÇÑ ¼­ºñ½º¿Í ³ú ±â´ÉÀ» Çâ»ó½ÃŰ´Â ¿îµ¿ÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖ´Â °í°´ »çÀÌ¿¡ À庮ÀÌ »ý±æ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °í°´Àº µðÁöÅÐ ³ú °Ç°­À» À§ÇØ Ç×»ó °í¼Ó ÀÎÅͳݿ¡ Á¢¼ÓÇÒ ¼ö ÀÖ¾î¾ß ÇÕ´Ï´Ù. µû¶ó¼­ ÀÎÅÍ³Ý ¿¬°áÀÌ ÁÁÁö ¾ÊÀº Áö¿ª¿¡¼­´Â ÀÌ·¯ÇÑ ¿ëµµ¸¦ ÀÌ¿ëÇÒ ¼ö ¾ø½À´Ï´Ù.

±âȸ :

  • ±â¼ú ÁÖµµÇü °¡Á¦Æ® »ç¿ë Áõ°¡
  • ¼¼°èÀûÀ¸·Î ±â¼ú ±â±âÀÇ »ç¿ëÀº ±× ¾î´À ¶§º¸´Ù ºü¸¥ ¼Óµµ·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¾ÆÀ̵éÀº ÀÌÁ¦ ¾î¸¥µéº¸´Ù ´õ ÀÚÁÖ Å×Å©³î·ÎÁö¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ û¼Ò³âµé »çÀÌ¿¡¼­ ÷´Ü ±â¼ú »ç¿ëÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú °Ç°­ ¹®Á¦¿Í ±â¼ú Áßµ¶À» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸é¼­ ¼¼°è »ç¶÷µéÀº ¾É¾Æ¼­ »ýȰÇÏ´Â ºÒ°Ç°­ÇÑ »ýȰ½À°üÀ» °®°Ô µÇ°í, ½É°¢ÇÑ Áúº´°ú Á¤½ÅÁúȯ¿¡ °É¸± À§ÇèÀÌ ³ô¾ÆÁý´Ï´Ù. µû¶ó¼­ µðÁöÅÐ µÎ³ú °Ç°­¹ý ¼¼°è ½ÃÀåÀº ÷´Ü ±â¼úÀÇ »ç¿ë Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

À§Çù:

  • ±ÔÁ¦¿Í µ¥ÀÌÅÍ º¸¾È ¹®Á¦
  • µðÁöÅÐ ³ú °Ç°­ ½ÃÀå¿¡¼­´Â Á¤½Å °Ç°­ ¹× ÀÎÁö ±â´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Á¦Ç° ¹× ¼­ºñ½º°¡ ÀÚÁÖ Á¦°øµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀÇ ¾ÈÀü¼º, À¯È¿¼º ¹× µµ´öÀû Àû¿ëÀ» º¸ÀåÇϱâ À§ÇØ ±ÔÁ¦ ±â°üÀº ƯÁ¤ °¡À̵å¶óÀΰú ±ÔÁ¦¸¦ ¸¶·ÃÇØ¾ß ÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ¸¹Àº µðÁöÅÐ ³ú °Ç°­ ¼Ö·ç¼ÇÀº ¹Î°¨ÇÑ °³ÀÎ µ¥ÀÌÅ͸¦ ¼öÁýÇÏ°í ºÐ¼®ÇØ¾ß ÇÕ´Ï´Ù. ÀÌ ÇÁ·ÒÇÁÆ®´Â µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã, º¸¾È ¹Ìºñ, ¼öÁýµÈ µ¥ÀÌÅÍÀÇ ÀáÀçÀû »ç¿ë ¹× ¾Ç¿ë¿¡ ´ëÇÑ ¿ì·Á¸¦ ºÒ·¯ÀÏÀ¸Åµ´Ï´Ù.

COVID-19ÀÇ ¿µÇâ :

  • °¢±¹ Á¤ºÎ°¡ ½ÃÇàÇÑ Äڷγª19 ÆÒµ¥¹Í ºÀ¼â Á¶Ä¡·Î ÀÎÇØ Á¤½Å°Ç°­°ú ÀÎÁö ±â´ÉÀÇ °¡Ä¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ µðÁöÅÐ ³ú °Ç°­ Á¦Ç° ¹× ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ¸¹Àº ÀÇ·á ±â°üµéÀÌ ÀÎÁö Æò°¡ ¹× ³ú ÈÆ·Ã °úÁ¤À» Á¦°øÇϱâ À§ÇØ µðÁöÅÐ µµ±¸¸¦ »ç¿ëÇÏ´Â µî ¿ø°Ý Áø·á ¸ðµ¨À» µµÀÔÇÏ°Ô µÇ¾ú½À´Ï´Ù. ±× °á°ú, ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý Áø·á ¸ðµ¨ÀÌ ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¸ðµ¨¿¡´Â À̹ø ÆÒµ¥¹Í ±â°£ µ¿¾È ³ú °Ç°­, ÀÎÁö Æò°¡ ¹× ³ú ÈÆ·Ã ÇÁ·Î±×·¥À» À§ÇÑ µðÁöÅÐ µµ±¸°¡ Æ÷ÇԵ˴ϴÙ.
  • ¿¹Ãø ±â°£ µ¿¾È ¼ÒÇÁÆ®¿þ¾î ºÐ¾ß°¡ °¡Àå Ŭ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀº Çϵå¿þ¾î ¼Ö·ç¼Ç¿¡ ºñÇØ À¯¿¬¼º, È®À强, °æÁ¦¼ºÀÌ ¶Ù¾î³ª±â ¶§¹®¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀº ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üÀÇ º¯È­ÇÏ´Â ¿ä±¸¿¡ µû¶ó ½±°Ô ¾÷µ¥ÀÌÆ®ÇÏ°í º¯°æÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ¾Û, ¿ø°Ý ÀÇ·á ¼Ö·ç¼Ç, ÀüÀÚ ÀÇ·á ±â·Ï µî ´Ù¾çÇÑ µðÁöÅÐ µµ±¸¿Í ¿ëµµÀÌ µðÁöÅÐ ³ú °Ç°­ ½ÃÀåÀÇ ¼ÒÇÁÆ®¿þ¾î ºÎ¹®¿¡ Æ÷ÇԵ˴ϴÙ. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ ȯÀÚ Ä¡·á¸¦ Áö¿øÇϰí Ä¡·á °á°ú¸¦ °³¼±Çϱâ À§ÇØ ÀÌ·¯ÇÑ ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀ» »ç¿ëÇÏ´Â °Íµµ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
  • ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÐ¾ß´Â È£½ºÇÇÅ»¸®Æ¼ ºÐ¾ßÀÔ´Ï´Ù.
  • ´Ù¾çÇÑ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÏ°í ³ú Áúȯ ȯÀÚ ¼ö°¡ ¸¹Àº º´¿ø ºÎ¹®ÀÌ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. µðÁöÅÐ ¼Ö·ç¼ÇÀº º´¿øÀÌ Á¶±â Áø´Ü, º¸´Ù È¿°úÀûÀÎ Ä¡·á, ȯÀÚ Ä¡·áÀÇ ´õ ³ªÀº °ü¸®¸¦ ÅëÇØ ȯÀÚ °á°ú¸¦ °³¼±ÇÏ°í ºñ¿ëÀ» Àý°¨ÇÏ¸ç ¿î¿µ È¿À²¼ºÀ» ³ôÀÏ ¼ö ÀÖµµ·Ï Áö¿øÇÔÀ¸·Î½á ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

ºÏ¹Ì´Â 2021³â µðÁöÅÐ ³ú °Ç°­ ¼¼°è ½ÃÀå¿¡¼­ »ó´çÇÑ ºñÁßÀ» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È¿¡µµ °è¼Ó Áö¹è·ÂÀ» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â Á¤½Å °Ç°­ ¾ÛÀÌ ³Î¸® »ç¿ëµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ¹Ì±¹¿¡¼­´Â ±¹¸³Á¤½Å°Ç°­¿¬±¸¼Ò¿¡ µû¸£¸é ¾à 5,290¸¸ ¸íÀÇ ¼ºÀÎÀÌ Á¤½ÅÁúȯÀ» ¾Î°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °í·ÉÈ­, ÀÎÁö °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ±â¼ú ¹ßÀü µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ºÏ¹Ì¿¡¼­µµ ½ÃÀåÀÌ ¹øÃ¢Çϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ³ú °Ç°­¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Àå¾ÖÀÇ ºÎ´ãÀº ÀÌ·¯ÇÑ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â µðÁöÅÐ ±â¼ú°ú ¼Ö·ç¼ÇÀ» Á¡Á¡ ´õ ¸¹ÀÌ µµÀÔÇÏ¿© ȯÀÚÀÇ Ä¡·á Á¢±Ù¼ºÀ» ³ôÀ̰í ȯÀÚ °á°ú¸¦ °³¼±ÇÏ¸ç ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ µðÁöÅÐ ³ú °Ç°­ ½ÃÀåÀº ÅõÀÚ Áõ°¡, Á¤½Å °Ç°­¿¡ ´ëÇÑ NGOÀÇ °ü½É, ¹®Á¦ ÀÎ½Ä Á¦°í Ä·ÆäÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º :

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´¿¡°Ô´Â ´ÙÀ½ Áß ÇϳªÀÇ ¹«·á ¸ÂÃãÈ­ ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, CAGR(Âü°í: Ÿ´ç¼º È®Àο¡ µû¶ó ´Ù¸§)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ¼Ò½º
    • °¡Á¤

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • ½ÅÇü Äڷγª¹ÙÀÌ·¯½º(COVID-19)ÀÇ ¿µÇâ

Á¦4Àå PorterÀÇ Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ µðÁöÅÐ ³ú °Ç°­ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ¼ÒÇÁÆ®¿þ¾î
  • µð¹ÙÀ̽º

Á¦6Àå ¼¼°èÀÇ µðÁöÅÐ ³ú °Ç°­ ½ÃÀå : ±â´Éº°

  • ÀÓ»ó ±â´É
  • °ü¸® ±â´É
  • Äɾî Ç÷£ ¹× °Ç°­ °ü¸®
  • ÀÓ»ó ÀÇ»ç°áÁ¤ Áö¿ø(CDS)
  • ÀüÀڰǰ­±â·Ï(EHR)
  • ÀüÀÚ Ã³¹æÀü
  • À繫 ±â´É
  • ¿ø°ÝÀÇ·á
  • ±âŸ ±â´É

Á¦7Àå ¼¼°èÀÇ µðÁöÅÐ ³ú °Ç°­ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå ¼¼°èÀÇ µðÁöÅÐ ³ú °Ç°­ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ÁÖ¿ä ¹ßÀü

  • °è¾à/ÆÄÆ®³Ê½Ê/Çù¾÷/ÇÕÀÛÅõÀÚ(JV)
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦10Àå ±â¾÷ °³¿ä

  • Advanced Oncotherapy PLC
  • Cerner Corporation
  • Core Solutions, Inc
  • Danfysik A/S
  • Hitachi, Ltd
  • Holmusk
  • IBA Worldwide
  • Qualifacts Systems, Inc
  • International Business Machines Corporation(IBM)
  • Linus Health
  • Medibio
  • Mevion Medical Systems, Inc
  • Netsmart Technologies
  • NXGN Management
  • Spring Care
  • The Echo Group
LSH 23.09.20

According to Stratistics MRC, the Global Digital Brain Health Market is accounted for $220.65 billion in 2023 and is expected to reach $411.19 billion by 2030 growing at a CAGR of 9.3% during the forecast period. Digital wellness is the use of technology to protect one's physical, mental, and cognitive health. Cognitive, social-emotional, sensory, behavioral, and motor functions of the brain are all indicators of brain health. To enhance cognitive function and promote brain health, the digital brain health market employs technology and digital tools. For people looking to maintain or enhance their cognitive performance, digital tools have the potential to provide practical, affordable, and personalized solutions.

According to the World Bank, around 1 billion people suffer from mental health conditions such as mild cognitive impairments, dyslexia, attention deficits, and Alzheimer's disease.

Market Dynamics:

Driver:

  • Rising prevalence of brain diseases.
  • Anxiety and depressive disorders affected more people in 2020 as a result of the COVID-19 pandemic, according to a digital brain health market analysis. Significant disruptions in thought, emotion, or behavior characterize mental disorders. Schizophrenia and post-traumatic stress disorder (PTSD) are examples of various disorders. Around 50 million people worldwide suffer from epilepsy, according to the WHO. As a result, it ranks among the most widespread neurological conditions worldwide. Nearly 80% of epilepsy sufferers reside in low- and middle-income nations.

Restraint:

  • Not accessible to all resources.
  • Not all applications are free due to the relatively new popularity of digital brain health. For some people, the free ones with in-app purchases might not be the best option. This creates a barrier between these services and the customers, who stand to benefit from exercises that improve brain function. In addition, customers must always have access to high-speed internet for their digital brain health. As a result, regions with poor internet connectivity are unable to utilize these applications.

Opportunity:

  • Increasing usage of technologically driven gadgets.
  • Globally, the use of technological devices is expanding at an unprecedented rate. Children are now using technological devices more frequently than adults. Particularly among teenagers, the use of cutting-edge technology has rapidly increased. Health problems and technology addiction might result from this. The population of the world, which is increasingly dependent on technology, is living a sedentary and unhealthy lifestyle, increasing their risk of contracting serious illnesses and mental disorders. The global market for digital brain health is thus being driven by the rise in the use of cutting-edge technology.

Threat:

  • Regulatory and data security issues.
  • Products and services with an impact on mental health and cognitive function are frequently offered in the digital brain health market. To ensure the safety, effectiveness, and moral application of these technologies, regulatory agencies may need to create specific guidelines and regulations. The gathering and analysis of sensitive personal data is necessary for many digital brain health solutions. This prompt is concerned about data privacy, security lapses, and potential uses and abuses of the collected data.

COVID-19 Impact:

  • The COVID-19 pandemic lockdown measures that were put in place by various governments have raised awareness of the value of mental health and cognitive function, which has increased demand for digital brain health products and services. Additionally, the pandemic has compelled numerous healthcare organizations to implement remote care models, which include using digital tools to deliver cognitive assessments and brain training courses. As a result, telehealth and remote care models have received more attention. These models include digital tools for brain health, cognitive assessments, and brain training programs during this pandemic period.
  • The software segment is expected to be the largest during the forecast period
  • Due to the greater flexibility, scalability, and affordability compared to hardware solutions, software solutions are predicted to hold the largest market share. Software solutions make it simpler to update and modify them to fit changing patient and healthcare provider needs. A wide range of digital tools and applications, including mobile apps, telehealth solutions, and electronic health records, are included in the software segment of the market for digital brain health. The use of these software solutions by healthcare providers to support patient care and enhance outcomes is also boosting the segment's growth.
  • The hospitals segment is expected to have the highest CAGR during the forecast period
  • Hospitals, which offer a wide range of healthcare services and have a high patient population with brain health disorders, are responsible for the majority of market growth in the anticipated time frame. By enabling earlier diagnosis, more effective treatment, and better management of patient care, digital solutions can also assist hospitals in improving patient outcomes, lowering costs, and increasing operational efficiency, which is propelling the growth of this segment.

Region with largest share:

North America held a sizable portion of the global market for digital brain health in 2021, and it is anticipated that it will continue to rule throughout the forecast period. This is a result of the widespread use of mental health apps. In the United States, approximately 52.9 million adults suffer from mental illness, according to the National Institute of Mental Health. Additionally, the market is also flourishing in this part of North America due to factors like an aging population, increased awareness of cognitive health, and technological advancements.

Region with highest CAGR:

The Asia Pacific region is expected to have the highest CAGR during the forecast period. The burden of disorders affecting brain health in Asia-Pacific is a major driver of this growth. Healthcare providers can increase patient access to care, improve patient outcomes, and lower costs by embracing digital technologies and solutions more and more. Additionally, the region's market for digital brain health is being driven by an increase in investments, interest among NGOs in mental health, and campaigns to raise awareness of the issue.

Key players in the market:

Some of the key players profiled in the Digital Brain Health Market include: Advanced Oncotherapy PLC, Cerner Corporation, Core Solutions, Inc., Danfysik A/S, Hitachi, Ltd, Holmusk, IBA Worldwide, Qualifacts Systems, Inc., International Business Machines Corporation (IBM), Linus Health, Medibio, Mevion Medical Systems, Inc, Netsmart Technologies, NXGN Management, Spring Care and The Echo Group.

Key Developments:

  • In June 2023, IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, and PARTICLE (Particle Therapy Interuniversity Center Leuven), located on the health sciences campus of the University Hospitals Leuven (UZ Leuven), today announced they have initiated a Research Partnership for the development of ConformalFLASH®
  • In June 2023, Holmusk, a leading global behavioral health real-world evidence company, announced today that it is joining forces with one of its strategic partners, Streamline Healthcare Solutions, to enhance care delivery using advanced analytics. The partnership marks the introduction of Holmusk's Management and Supervision Tool (MaST), which is widely used by the National Health Service in the United Kingdom, to a U.S. market.
  • In February 2023, The province of Nova Scotia, in collaboration with Nova Scotia Health Authority (NSHA) and IWK Health (IWK), announced today a new 10-year agreement has been signed with Oracle Cerner to implement an integrated electronic care record across the province for the more than one million Nova Scotians. This technology can help improve the way health professionals use and share patient information.
  • In January 2023, Mersey Care NHS Foundation Trust are delighted to announce a collaboration with long term partners Holmusk[i] and the University of Liverpool to establish a mental health analytics and research hub to translate mental health research into results that directly benefit people.

Components Covered:

  • Software
  • Devices

Functionalities Covered:

  • Clinical Functionality
  • Administrative Functionality
  • Care Plans/Health Management
  • Clinical Decision Support (CDS)
  • Electronic Health Records (EHR)
  • E-Prescribing
  • Financial Functionality
  • Telehealth
  • Other Functionalities

End Users Covered:

  • Hospitals
  • Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026 and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Brain Health Market, By Component

  • 5.1 Introduction
  • 5.2 Software
  • 5.3 Devices

6 Global Digital Brain Health Market, By Functionality

  • 6.1 Introduction
  • 6.2 Clinical Functionality
  • 6.3 Administrative Functionality
  • 6.4 Care Plans/Health Management
  • 6.5 Clinical Decision Support (CDS)
  • 6.6 Electronic Health Records (EHR)
  • 6.7 E-Prescribing
  • 6.8 Financial Functionality
  • 6.9 Telehealth
  • 6.10 Other Functionalities

7 Global Digital Brain Health Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Specialty Clinics
  • 7.4 Other End Users

8 Global Digital Brain Health Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Advanced Oncotherapy PLC
  • 10.2 Cerner Corporation
  • 10.3 Core Solutions, Inc.
  • 10.4 Danfysik A/S
  • 10.5 Hitachi, Ltd
  • 10.6 Holmusk
  • 10.7 IBA Worldwide
  • 10.8 Qualifacts Systems, Inc.
  • 10.9 International Business Machines Corporation (IBM)
  • 10.10 Linus Health
  • 10.11 Medibio
  • 10.12 Mevion Medical Systems, Inc
  • 10.13 Netsmart Technologies
  • 10.14 NXGN Management
  • 10.15 Spring Care
  • 10.16 The Echo Group
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦